Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

MDR-001

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

MindRank AI Ltd · Phase 1/2 · Completed · Enrollment 128

NCT06778850

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
MDR-001(SAD)n/rn/rn/rn/r
Placebo (SAD)n/rn/rn/rn/r
MDR-001 (MAD)n/rn/rn/rn/r
Placebo (MAD)n/rn/rn/rn/r

Not shown

  • MDR-001(SAD): endpoint not reported
  • Placebo (SAD): endpoint not reported
  • MDR-001 (MAD): endpoint not reported
  • Placebo (MAD): endpoint not reported